HOW IT WORKS

What happens in knee osteoarthritis (OA)

Knee OA is the result of mechanical, cellular, and biochemical processes.

Healthy cartilage, which is composed of water, collagen, and proteoglycans, continually remodels itself as chondrocytes replace macromolecules lost through degradation. OA disrupts this process, leading to increased degeneration and an abnormal repair response. (22) The mechanical, cellular, and biochemical interactions associated with OA may cause inflammation, stiffness and reduced mobility, synovial changes, and progressive degeneration.


Mechanism of Action Video

Watch a short video about how SUPARTZ FX treats osteoarthritis (OA) of the knee. In targeting mechanical and cellular levels in animal models and biochemical levels in cell cultures, SUPARTZ FX inhibits IL-1β, MMP-3, and NO pathways, leading to reduced pain and inflammatory reactions and protects nociceptors, which also reduces OA knee pain.*


The Science of SUPARTZ FX

SUPARTZ FX targets the mechanical, cellular, and biochemical processes of knee OA.

Mechanical*
In animal models, SUPARTZ FX:

  • Increased cartilage integrity (23)
  • Reduced cell death (24)
  • Improved joint morphology (24)

Cellular*
In animal models, SUPARTZ FX:

  • Reduced synovitis (25)
  • Stimulated endogenous HA production (25)
  • Penetrated damaged cartilage to promote repair (26)
  • In a large-animal model of ACLT-induced OA, SUPARTZ FX significantly increased the production of endogenous hyaluronic acid (bright spots) in synovial tissue (25)

Biochemical*
In cultured cells, SUPARTZ FX:

  • Reduced levels of pro-inflammatory cytokines (27,28)
  • Reduced production of cartilage-degrading enzymes (29,30)

Benefits of HA

  • A recent analysis found treatment with HA including SUPARTZ FX was more effective in relieving the pain of knee osteoarthritis for up to 3 months than any of the oral drugs commonly used. (14)
  • Local injections of HA including SUPARTZ FX to treat knee osteoarthritis are safer than oral drugs that can cause side effects that affect functions of the stomach, heart, or kidneys. (14)


Benefits of SUPARTZ FX

In clinical experience, SUPARTZ FX has been shown to relieve OA knee pain:

  • SUPARTZ FX significantly relieved OA pain, a long-lasting benefit that lasted at least 18 weeks, in a multicenter, prospective, randomized, double-blind, placebo-controlled study of 240 patients with knee OA (15)
  • In an integrated analysis of 5 clinical studies, SUPARTZ FX yielded a significantly greater reduction in pain compared with saline (12)
  • In a retrospective analysis of a healthcare claims database of about 79 million patients, HA treatment, including SUPARTZ FX, delayed the time to total knee replacement by up to 3.6 years** (17)
  • SUPARTZ FX has an unsurpassed history of safe clinical use with an adverse event profile comparable to intra-articular injections of saline (12)
  • With its effectiveness on relieving knee pain and improving function, combined with an excellent safety profile, intra-articular hyaluronic acid, such as SUPARTZ FX, is an ideal treatment option for the management of knee
    OA (14)

Median time to TKR is directly correlated with
the number of courses of HA therapy (14)

*The clinical relevance of this information has not been determined.
Based on effect sizes for pain at 3 months; statistically significant in comparison to acetaminophen, celecoxib, and naproxen
**TKR Delay with > or = 5 HA treatment courses

SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found here or by contacting customer service at
800-396-4325.